3Gaa J,Rummeny EJ,Seemann MD.Whole-body imaging with PET/MRI [J].Eur J Med Res,2004,9(6):309-312.
4van de Wouw AJ,Janssen-Heijnen ML,Coebergh JW,et al.Epidemiology of unknown primary tumours;incidence and population-based survival of 1 285 patients in Southeast Netherlands,1984-1992 [J].Eur J Cancer,2002,38(3):409-413.
5Kambhu SA,Kelsen DP,Fiore J,et al.Metastatic adenocarcinoma of unknown primary site. Prognostic variables and treatment results [J].Am J Clin Oncol,1990,13(1):55-60.
6Hainsworth JD,Burris HA Ⅲ,Calvert SW,et al.Gemcitabine,carboplatin,and paclitaxel for patients with carcinoma of unknown primary site:a phase Ⅱ trial of the Minnie Pearl Cancer Research Network [J].Cancer Intest,2001,19(4):335-339.
7Greco FA,Burris HA Ⅲ,Litchy S,et al.Gemcitabine,carboplatin,and paclitaxel for patients with carcinoma of unknown primary site:a Minnie Pearl Cancer Research Network study [J]. J Clin Oncol,2002,20(6):1651-1656.
8Piga A,Nortilli R,Cetto GL,et al.Carboplatin,doxorubicin and etoposide in the treatment of tumours of unknown primary site [J].Br J Cancer,2004,90(10):1898-1904.
9van de Wouw AJ,Jansen RL,Grifnoen AW,et al.Clinical and immunohistochemical analysis of patients with unknown primary tumour,A search for prognostic factors in UPT [J]. Anticancer Res,2004,24(1):297-301.
10Hedley DW,Leary JA,Kirsten F.Metastatic adenocarcinoma of unknown primary site: abnormalities of cellar DNA content and survival [J].Eur J Cancer Clin Oncol,1985, 21(2):185-189.
